Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc > Willow Shareholders Future

<< Previous

Bullboard Posts

Next >>

Comment by Bullknit101on Jul 09, 2021 8:33am

206 Views

Post# 33520264

RE:Willow Shareholders Future

It will be interesting to se what happens in the coming months. It seems biosythesis is gaining momentum and others like InMed, Demetrix, Gingko are gaining ground on the manufacturing of cannabinoids front. Cash is king so if they burn through it too quickly, we'll more cash raises and dilutive activity.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario